|
Main
|
|
Note: This record shows only 22 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register. |
|
Register:
|
ClinicalTrials.gov |
|
Last refreshed on:
|
29 June 2015 |
|
Main ID: |
NCT02467257 |
|
Date of registration:
|
04/06/2015 |
|
Prospective Registration:
|
No |
|
Primary sponsor: |
|
|
Public title:
|
Gum Arabic as Fetal Hemoglobin Agent in Sickle Cell Anemia
|
|
Scientific title:
|
Potential Role of Gum Arabic as Fetal Hemoglobin Agent in Sudanese Sickle Cell Anemia Patients |
|
Date of first enrolment:
|
April 2014 |
|
Target sample size:
|
47 |
|
Recruitment status: |
Completed |
|
URL:
|
http://clinicaltrials.gov/show/NCT02467257 |
|
Study type:
|
Interventional |
|
Study design:
|
Allocation: Non-Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Treatment
|
|
Phase:
|
Phase 1/Phase 2
|
|
|
Countries of recruitment
|
|
Sudan
| | | | | | | |
|
Contacts
|
|
Name:
|
Amal M Saeed, PhD |
|
Address:
|
|
|
Telephone:
|
|
|
Email:
|
|
|
Affiliation:
|
University of Khartoum Faculty of Medicine Department of Physiology |
|
|
Name:
|
Lamis AA Kaddam, MSc |
|
Address:
|
|
|
Telephone:
|
|
|
Email:
|
|
|
Affiliation:
|
Department of physiology Faculty of Medicine Alneelain University Khartoum, |
| |
|
Key inclusion & exclusion criteria
|
Inclusion Criteria:
1. over 5 year old
2. less t5han 50
3. diagnosed with homozygous sickle cell anemia by Hb electrophoresis
Exclusion Criteria:
1. patients received blood transfusion within the last three months or admitted to the
hospital within 2 weeks because of Sickle cell anemia -related events or crisis.
Age minimum:
5 Years
Age maximum:
50 Years
Gender:
Both
|
|
Health Condition(s) or Problem(s) studied
|
|
Sickle Cell Anemia
|
|
Intervention(s)
|
|
Dietary Supplement: Gum Arabic
|
|
Primary Outcome(s)
|
|
The primary endpoint of the study will be the level of fetal hemoglobin after three months
[Time Frame: 12 weeks]
|
|
Secondary ID(s)
|
|
AlNeelainU
|
|
Source(s) of Monetary Support
|
|
Please refer to primary and secondary sponsors
|
|
Results
|
|
Results available:
|
|
|
Date Posted:
|
|
|
Date Completed:
|
|
|
URL:
|
|
|
|